GE Healthcare Acquires Nihon Medi-Physics, Enhancing Precision Care in Japan's Radiopharmaceutical Market

GE Healthcare is set to take full ownership of Nihon Medi-Physics (NMP) by purchasing the remaining 50% stake from Sumitomo Chemical, solidifying its footprint in Japan's significant molecular imaging market, valued at $7 billion[1][2]. This strategic acquisition, anticipated to close by early 2025, aligns with GE Healthcare's commitment to enhancing its precision care strategy, particularly in regions that are adopting precision medicine[1]. NMP, a Japanese company with 13 manufacturing facilities, specializes in radiopharmaceuticals for neurology, cardiology, and oncology, and generated approximately $183 million in revenues in 2023[1][2]. Although initially expected to be earnings neutral, the acquisition is projected to become accretive in the future, further strengthening GE Healthcare's position in the global imaging market[1].